3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
12
Spondylitis, Ankylosing
4
Psoriasis
2
Inflammatory Bowel Diseases
2
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammation
1
Infections
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Crohn Disease
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis, Psoriatic
1
Arthritis
1
Interventions
telitacicept
2
Prednisone
2
Blood Specimen Collection
2
thymoglobulin
1
remdesivir
1
prednylidene
1
fludarabine
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
apremilast
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Music Therapy
1
Methods
1
Melphalan
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Infliximab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Autoimmune Diseases
×
Adalimumab
×
Clear all
NCT01793519
2024-02-28
STARA
Georgetown University
Phase 4
Unknown
290 enrolled